Cost-effectiveness of computed tomography screening for lung cancer in the United States

Journal of Thoracic Oncology

Volumn 6, Issue 11, 2011, Pages 1841-1848

  McMahon, Pamela M ^a,b   Kong, Chung Yin ^a,b   Bouzan, Colleen ^a   Weinstein, Milton C ^c,d   Cipriano, Lauren E ^a,e   Tramontano, Angela C ^a   Johnson, Bruce E ^c,f   Weeks, Jane C ^c,g   Gazelle, G Scott ^a,b,d  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b Department of Radiology ^*  (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e Stanford University   (United States)

^f Lowe Center for Thoracic Oncology   (United States)

^g DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Cost utility analysis; Lung cancer; Microsimulation model; Screening

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER SCREENING; COMPUTER ASSISTED TOMOGRAPHY; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; DIAGNOSTIC IMAGING; FEMALE; HUMAN; LIFESPAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; RADIATION INDUCED NEOPLASM; SIMULATION; SMOKING CESSATION; SMOKING CESSATION PROGRAM; UNITED STATES;

EID: 80054893661     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e31822e59b3     Document Type: Article

References (43)

1. National Lung Screening Trial Results, 2010. Available at http://www. cancer.gov/newscenter/pressreleases/NLSTresultsRelease. Accessed November 4, 2010.
2. National Lung Screening Trial Research Team, Aberle DR, Berg CD, Black WC, et al. The National Lung Screening Trial: overview and study design. Radiology 2011;258:243-253.
3. Dominioni L, Rotolo N, Poli A, et al. Self-selection effects in smokers attending lung cancer screening: a 9.5-year population-based cohort study in Varese, Italy. J Thorac Oncol 2010;5:428-435.
4. Cox LS, Clark MM, Jett JR, et al. Change in smoking status after spiral chest computed tomography scan screening. Cancer 2003;98:2495-2501. (Pubitemid 37466666)
5. Townsend CO, Clark MM, Jett JR, et al. Relation between smoking cessation and receiving results from three annual spiral chest computed tomography scans for lung carcinoma screening. Cancer 2005;103: 2154-2162. (Pubitemid 40605124)
6. Taylor KL, Cox LS, Zincke N, et al. Lung cancer screening as a teachable moment for smoking cessation. Lung Cancer 2007;56:125-134. (Pubitemid 46356640)
7. Park E, Ostroff J, Gareen I, et al. Risk perceptions among national lung screening trial participants. Ann Behav Med 2009;37:268-279.
8. Ashraf H, Tonnesen P, Pedersen JH, et al. Smoking habits were unaffected by CT screening at 1-year follow-up in the Danish Lung Cancer Screening Trial (DLCST). Thorax 2008;64:388-392.
9. van der Aalst CM, van den Bergh KA, Willemsen MC, et al. Lung cancer screening and smoking abstinence: 2 year follow-up data from the Dutch-Belgian randomised controlled lung cancer screening trial. Thorax 2010;65:600-605.
10. McMahon PM, Kong CY, Johnson BE, et al. Estimating long-term effectiveness of lung cancer screening in the Mayo CT screening study. Radiology 2008;248:278-287.
11. McMahon PM, Kong CY, Weinstein MC, et al. Adopting helical CT screening for lung cancer: potential health consequences during a 15-year period. Cancer 2008;113:3440-3449.
12. Mahadevia P, Fleisher L, Frick K, et al. Lung cancer screening with helical computed tomography in older adult smokers. JAMA 2003;289: 313-322.
13. Model profiler of the MGH-ITA Lung Cancer Policy Model. CISNET. Available at: http://cisnet.cancer.gov/profiles/. Accessed May 6, 2010.
14. The Commit Research Group. Community Intervention Trial for Smoking Cessation (COMMIT): II. Changes in adult cigarette smoking prevalence. Am J Public Health 1995;85:193-200.
15. Jorenby DE, Leischow SJ, Nides MA, et al. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med 1999;340:685-691. (Pubitemid 29110752)
16. Prevention and Cessation of Cigarette Smoking: Control of Tobacco Use (PDQ(R)), Health Professional Version. U.S. National Institutes of Health, 2008. Available at: www.cancer.gov/cancertopics/pdq/prevention/control-of-tobacco- use/HealthProfessional. Accessed February 5, 2009.
17. Hughes JR, Stead LF, Lancaster T. Antidepressants for smoking cessation. Cochrane Database Syst Rev 2007:CD000031. Review.
18. Stead LF, Perera R, Bullen C, et al. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 2008:CD000146.
19. Paluck EC, McCormack JP, Ensom MH, et al. Outcomes of bupropion therapy for smoking cessation during routine clinical use. Ann Pharma-cother 2006;40:185-190. (Pubitemid 43269845)
20. Cipriano LE, Romanus D, Earle CC, et al. Lung cancer treatment costs, including patient responsibility, by stage of disease and treatment modality, 1992-2003. Value Health 2010;14:41-52.
21. Hanmer J, Lawrence W, Anderson J, et al. Report of nationally representative values for the non-institutionalized US adult population for seven health related quality of life scores. Med Decis Making 2006;26: 391-400. (Pubitemid 44050843)
22. Earle C, Chapman R, Baker C, et al. Systematic overview of cost-utility assessments in oncology. J Clin Oncolgy 2000;18:3302-3317.
23. Handy JR Jr, Asaph JW, Skokan L, et al. What happens to patients undergoing lung cancer surgery? Outcomes and quality of life before and after surgery. Chest 2002;122:21-30. (Pubitemid 34754138)
24. van den Hout WB, Kramer GW, Noordijk EM, et al. Cost-utility analysis of short- versus long-course palliative radiotherapy in patients with non-small-cell lung cancer. J Natl Cancer Inst 2006;98:1786-1794. (Pubitemid 46017930)
25. Balduyck B, Hendriks J, Lauwers P, et al. Quality of life evolution after lung cancer surgery: a prospective study in 100 patients. Lung Cancer 2007;56:423-431. (Pubitemid 46679085)
26. Gold MR, Siegel JE, Russell LB, et al. Cost-Effectiveness in Health and Medicine. New York: Oxford University Press, 1996.
27. Cannon J, Win T. Long-term quality of life after lung resection. Thorac Surg Clin 2008;18:81-91. (Pubitemid 351180017)
28. Xu DM, Gietema H, de Koning H, et al. Nodule management protocol of the NELSON randomised lung cancer screening trial. Lung Cancer 2006;54:177-184. (Pubitemid 44802721)
29. Bach PB, Jett JR, Pastorino U, et al. Computed tomography screening and lung cancer outcomes. JAMA 2007;297:953-961. (Pubitemid 46376749)
30. Chien CR, Chen TH. Mean sojourn time and effectiveness of mortality reduction for lung cancer screening with computed tomography. Int J Cancer 2008;122:2594-2599. (Pubitemid 351590496)
31. Manser R, Dalton A, Carter R, et al. Cost-effectiveness analysis of screening for lung cancer with low dose spiral CT (computed tomography) in the Australian setting. Lung Cancer 2005;48:171-185.
32. Plevritis S, Sigal B. Estimating the stage shift and mortality reduction from CT lung cancer screening. Chicago, IL: Radiological Society of North America, 2003.
33. Gorlova OY, Amos C, Henschke C, et al. Genetic susceptibility for lung cancer: interactions with gender and smoking history and impact on early detection policies. Hum Hered 2003;56:139-145. (Pubitemid 37465080)
34. Foy M, Yip R, Chen X, et al. Modeling the mortality reduction due to computed tomography screening for lung cancer. Cancer 2011;117: 2703-2708.
35. Pignone M, Saha S, Hoerger T, et al. Cost-effectiveness analyses of colorectal cancer screening: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 2002;137:96-104. (Pubitemid 34779153)
36. Stout NK, Rosenberg MA, Trentham-Dietz A, et al. Retrospective cost-effectiveness analysis of screening mammography. J Natl Cancer Inst 2006;98:774-782. (Pubitemid 43983301)
37. Hall S, Lightwood J, Humfleet G, et al. Cost-effectiveness of bupropion, nortriptyline, and psychological intervention in smoking cessation. J Behav Health Serv Res 2005;32:381-392. (Pubitemid 43196922)
38. Fiscella K, Franks P. Cost-effectiveness of the transdermal nicotine patch as an adjunct to physicians' smoking cessation counseling. JAMA 1996;275:1247-1251. (Pubitemid 26118498)
39. Krumholz HM, Weintraub WS, Bradford WD, et al. Task force #2-the cost of prevention: can we afford it? Can we afford not to do it? 33rd Bethesda Conference. J Am Coll Cardiol 2002;40:603-615. (Pubitemid 34925607)
40. Kenfield SA, Wei EK, Rosner BA, et al. Burden of smoking on cause-specific mortality: application to the Nurses' Health Study. Tobacco control 2010;19:248-254.
41. Fryback DG, Palta M, Cherepanov D, et al. Comparison of 5 health-related quality-of-life indexes using item response theory analysis. Med Decis Making 2010;30:5-15.
42. van den Bergh KA, Essink-Bot ML, van Klaveren RJ, et al. Informed participation in a randomised controlled trial on CT screening for lung cancer. Eur Respir J [published online ahead of print March 12, 2009] doi: 10.1183/09031936.00098908.
43. Berrington de Gonzalez A, Kim KP, Berg CD. Low-dose lung computed tomography screening before age 55: estimates of the mortality reduction required to outweigh the radiation-induced cancer risk. J Med Screen 2008;15:153-158.